ImmunoScape’s Andreas Wilm offers a behind the scenes look at the machine learning models we trained for research published in Cell Press' Cell Reports – which...
Oct 19, 2023
ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research ImmunoScape’s platform accelerates...
Feb 15, 2023
Ayesha Siddiqui from BioSpectrum Asia spoke with our CEO and Co-Founder Choon-Peng (Choon) Ng about the progress around cancer research in Asia for her recent piece....
Jan 20, 2023
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and...
Jan 19, 2023
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and...
Oct 15, 2022
Andreas Wilm, Director of Computational Biology and Lorenz Gerber, Associate Director of Software Engineering at ImmunoScape contributed a blog post for Amazon Web...
Oct 1, 2022
ImmunoScape's CEO Choon-Peng Ng is featured in Endpoints. Endpoints highlights ImmunoScape's $14M funding round, our use of machine learning to discover TCR-T cell...
Sep 14, 2022
ImmunoScape To Present at the 7th Annual CAR-TCR Summit San Diego, California and Singapore – September 14, 2022 – ImmunoScape, a pre-clinical biotechnology company...
Sep 14, 2022
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors Anzu Partners led the $14M financing round with...